CN113694196A - Gold-induced polypyrrole/manganese dioxide nano material and preparation method and application thereof - Google Patents
Gold-induced polypyrrole/manganese dioxide nano material and preparation method and application thereof Download PDFInfo
- Publication number
- CN113694196A CN113694196A CN202110915680.XA CN202110915680A CN113694196A CN 113694196 A CN113694196 A CN 113694196A CN 202110915680 A CN202110915680 A CN 202110915680A CN 113694196 A CN113694196 A CN 113694196A
- Authority
- CN
- China
- Prior art keywords
- polypyrrole
- gold
- induced
- manganese dioxide
- auppy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 title claims abstract description 88
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 59
- 229920000128 polypyrrole Polymers 0.000 title claims abstract description 50
- 229910052737 gold Inorganic materials 0.000 title claims abstract description 46
- 239000010931 gold Substances 0.000 title claims abstract description 46
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 12
- 239000007800 oxidant agent Substances 0.000 claims abstract description 11
- 230000001590 oxidative effect Effects 0.000 claims abstract description 11
- 239000002245 particle Substances 0.000 claims abstract description 8
- 238000001959 radiotherapy Methods 0.000 claims description 22
- 238000003756 stirring Methods 0.000 claims description 18
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 239000002244 precipitate Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 239000000178 monomer Substances 0.000 claims description 6
- 239000012286 potassium permanganate Substances 0.000 claims description 6
- 239000003381 stabilizer Substances 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 150000004683 dihydrates Chemical class 0.000 claims description 3
- 238000007626 photothermal therapy Methods 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 3
- XYYVDQWGDNRQDA-UHFFFAOYSA-K trichlorogold;trihydrate;hydrochloride Chemical compound O.O.O.Cl.Cl[Au](Cl)Cl XYYVDQWGDNRQDA-UHFFFAOYSA-K 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 20
- 238000006116 polymerization reaction Methods 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 6
- 230000000637 radiosensitizating effect Effects 0.000 abstract description 4
- 210000004881 tumor cell Anatomy 0.000 abstract description 3
- 238000012827 research and development Methods 0.000 abstract description 2
- 239000002114 nanocomposite Substances 0.000 description 40
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 10
- 229910052760 oxygen Inorganic materials 0.000 description 10
- 239000001301 oxygen Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229960003180 glutathione Drugs 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 108010024636 Glutathione Proteins 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 2
- 238000000026 X-ray photoelectron spectrum Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- GOPYZMJAIPBUGX-UHFFFAOYSA-N [O-2].[O-2].[Mn+4] Chemical compound [O-2].[O-2].[Mn+4] GOPYZMJAIPBUGX-UHFFFAOYSA-N 0.000 description 1
- 230000005260 alpha ray Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005250 beta ray Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000007415 particle size distribution analysis Methods 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000002534 radiation-sensitizing agent Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 238000000733 zeta-potential measurement Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/0605—Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
- C08G73/0611—Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only one nitrogen atom in the ring, e.g. polypyrroles
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Optics & Photonics (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the technical field of biological medicines, and particularly relates to a gold-induced polypyrrole/manganese dioxide nano material as well as a preparation method and application thereof. The gold-containing oxidant is induced to initiate oxidative polymerization to prepare polypyrrole for the first time, and the preparation method is simple and controllable in particle size; the obtained material has good biocompatibility, good radiosensitization and photothermal effects, can obviously improve the tumor microenvironment, can achieve the effect of obviously killing tumor cells by synergy after reaching the tumor part, has small damage degree to the organism and high safety, and has good drug research and development prospect.
Description
Technical Field
The invention belongs to the technical field of biological medicines. More particularly, relates to a gold-induced polypyrrole/manganese dioxide nano material, and a preparation method and application thereof.
Background
Cancer is one of the diseases with the highest fatality rate worldwide, and the number of patients rapidly rises every year, which is a public health problem seriously threatening the survival of human beings. The traditional method for treating cancer mainly comprises surgery, radiotherapy and chemotherapy at present; the radiotherapy (radiotherapy) is a local non-invasive tumor treatment strategy widely used clinically, and uses alpha, beta and gamma ray beams and electron beams to directly damage DNA molecules of tumor cells or generate free radicals to induce apoptosis so as to kill cancer cells. However, single radiotherapy generally requires higher radiation intensity to achieve clinically desirable therapeutic effects, and the toxic and side effects on surrounding normal tissues are increased, which greatly affects the quality of life of patients; in addition, the tumor microenvironment is a severe hypoxic environment, thereby greatly reducing the effect of oxygen-dependent radiotherapy.
In recent years, researchers find that nano materials containing high atomic number metal elements (such as gold, tungsten, bismuth and the like) can be used as radiosensitizers, and the radiotherapy efficiency is improved by enhancing the deposition of ray energy in tumor tissues. For example, the chinese patent application CN108356279A discloses a method for preparing a hollow gold nano material, the prepared hollow gold nano material can be directly loaded with drug molecules, and the effect of treating tumors can be achieved by combining methods such as drug chemotherapy and the like while radiosensitization. However, the problem that the tumor microenvironment hypoxia condition affects the radiotherapy effect still exists, and the conditions of radiation enhancement and toxic and side effects increase are caused. Therefore, a novel medicine which has the effect of sensitizing radiotherapy and can supply oxygen is urgently needed clinically to solve the problems faced by the existing radiotherapy.
Disclosure of Invention
The invention aims to solve the technical problems that the radiation enhancement of the existing tumor radiotherapy can damage normal cells to different degrees, and the improvement of the radiotherapy effect by utilizing a radiosensitizer is limited, and provides a gold-induced polypyrrole/manganese dioxide nano material which can obviously enhance the radiotherapy effect and improve the anti-tumor effect.
The invention aims to provide a preparation method of a polypyrrole/manganese dioxide nano material.
The invention also aims to provide the application of the gold-induced polypyrrole/manganese dioxide nano material in preparing a medicament for preventing and treating tumors.
The above purpose of the invention is realized by the following technical scheme:
a preparation method of gold-induced polypyrrole/manganese dioxide nano material comprises the following steps:
s1, mixing the stabilizer, the oxidant and the pyrrole monomer, stirring and reacting at 4-40 ℃, centrifuging, and collecting precipitates to obtain the polypyrrole nano material;
s2, preparing the polypyrrole nano material obtained in the step S1 into a polypyrrole aqueous solution, adding potassium permanganate, reacting completely at 20-60 ℃, centrifuging, collecting precipitate, and performing post-treatment to obtain the polypyrrole nano material;
wherein the oxidant is selected from one or more of tetrachloroauric acid trihydrate, tetrachloroauric acid dihydrate, sodium tetrachloroauric acid and potassium tetrachloroauric acid.
Further, in step S1, the stabilizer is selected from one or more of polyvinyl alcohol, polyvinylpyrrolidone, and sodium lauryl sulfate.
Further, in step S1, the amount of the stabilizer added is 0.1 to 10 mg/mL.
Further, in step S1, the oxidant is added after being prepared into a solution, the concentration of the oxidant solution is 0.01-30 mM, the addition amount is 1-10 mL, and the solvent is water.
Further, in step S1, the volume ratio of the pyrrole monomer to the total volume of the solution is 1: (10-200).
Preferably, in step S1, the stirring reaction time is 1 to 60 minutes, and the stirring rotation speed is 200 to 1500 rpm.
Further, in step S2, the concentration ratio of the potassium permanganate to the polypyrrole nano-material in the aqueous solution is 1 (0.5-3).
Preferably, in step S2, the reaction time is 0.5 to 2 hours, and stirring may be performed during the reaction, wherein the stirring speed is 100 to 1500 rpm.
Preferably, in the steps S1 and S2, the rotation speed of the centrifugation is 5000-30000 rpm, and the centrifugation time is 5-30 min.
In addition, the invention also provides a gold-induced polypyrrole/manganese dioxide nano material prepared by the preparation method.
Further, the particle size of the gold-induced polypyrrole/manganese dioxide nano material is 5-200 nm.
Still further, the gold-induced polypyrrole/manganese dioxide nanomaterial has a dodecahedral, cubic, spherical, rod-like, or irregular polyhedral structure.
In addition, the invention also provides application of the gold-induced polypyrrole/manganese dioxide nano material in preparing a medicine for preventing and treating tumors.
Preferably, the medicine can be combined with photothermal therapy and radiation therapy when treating tumors, so that better tumor removal and treatment effects can be achieved.
The gold-induced polypyrrole/manganese dioxide nano material provided by the invention is induced by a gold-containing oxidant for the first time to initiate oxidative polymerization to prepare polypyrrole, so that a gold element exists in the prepared nano material, the gold-induced polypyrrole/manganese dioxide nano material has a radiosensitization effect, and the radiotherapy effect can be obviously improved; the manganese dioxide is coated on the periphery of the material, so that the oxygen concentration of a tumor microenvironment can be obviously improved under an anoxic tumor specific microenvironment, the anti-tumor effect of an oxygen-dependent radiotherapy method is further enhanced, the radiation intensity required by radiotherapy is synergistically reduced from the two aspects, and the damage of radiotherapy to organism tissues is obviously reduced. In addition, the gold-induced polypyrrole/manganese dioxide nano material provided by the invention has a photo-thermal property, and can exert a strong photo-thermal effect to cauterize tumors under the laser stimulation of a near-infrared region II. After the gold-induced polypyrrole/manganese dioxide nano material provided by the invention is further targeted to a tumor part, the gold-induced polypyrrole/manganese dioxide nano material is cooperated with a photothermal therapy and/or a radiotherapy, so that a better tumor treatment effect can be achieved.
The invention has the following beneficial effects:
the invention provides a gold-induced polypyrrole/manganese dioxide nano material, which is prepared by inducing an oxidizing agent containing gold to initiate oxidative polymerization for the first time, and has the advantages of simple preparation method and controllable particle size; the obtained material has good biocompatibility, good radiosensitization and photothermal effects, can obviously improve the tumor microenvironment, can achieve the effect of obviously killing tumor cells by synergy after reaching the tumor part, has small damage degree to the organism and high safety, and has good drug research and development prospect.
Drawings
FIG. 1 is an electron microscope scanning image of AuPPy nano-material obtained in example 1 of the present invention.
FIG. 2 shows AuPPy @ MnO obtained in example 1 of the present invention2Electron microscopy scan of nanocomposite.
FIG. 3 shows AuPPy @ MnO obtained in example 1 of the present invention2Energy dispersive X-ray spectroscopy of the nanocomposites.
FIG. 4 shows AuPPy nanomaterial and AuPPy @ MnO obtained in example 1 of the present invention2X-ray photoelectron spectrum of the nanocomposite.
FIG. 5 shows AuPPy nanomaterial and AuPPy @ MnO obtained in example 1 of the present invention2Particle size distribution profile of the nanocomposite.
FIG. 6 shows AuPPy nanomaterial and AuPPy @ MnO obtained in example 1 of the present invention2Zeta potential profile of the nanocomposite.
FIG. 7 shows AuPPy @ MnO obtained in example 1 of the present invention2Ultraviolet-visible spectrum of the nanocomposite.
FIG. 8 shows AuPPy @ MnO obtained in example 1 of the present invention2A photo-thermal performance evaluation graph of the nanocomposite; wherein, A-1064nm laser excitation, B-photo-thermal stability evaluation chart.
FIG. 9 shows AuPPy @ MnO obtained in example 1 of the present invention2Statistical map of the oxygen production capacity of the nanocomposite.
FIG. 10 shows AuPPy @ MnO obtained in example 1 of the present invention2Glutathione consumption capacity study statistical chart of the nano composite material.
Detailed Description
The invention is further described with reference to the drawings and the following detailed description, which are not intended to limit the invention in any way. Reagents, methods and apparatus used in the present invention are conventional in the art unless otherwise indicated.
Unless otherwise indicated, reagents and materials used in the following examples are commercially available.
Example 1 gold-induced polypyrrole/manganese dioxide nanomaterial
The preparation method of the gold-induced polypyrrole/manganese dioxide nano material comprises the following steps:
s1 preparation of gold-induced polymerized polypyrrole nano material (AuPPy)
Adding 10mL of deionized water into a 50mL single-neck round-bottom flask, adding 50mg of polyvinyl alcohol, mildly stirring at a heating environment of 90 ℃, condensing and refluxing for 1 hour, and naturally cooling to room temperature; dropwise adding 5mL of tetrachloroauric acid trihydrate aqueous solution (10mM) under the stirring condition of the rotation speed of 500-1200 rpm, and continuously stirring for 1 hour; dropwise adding 200 mu L of pyrrole monomer, and stirring at 500-1200 rpm for reaction for 15 minutes; centrifuging the reaction solution for 20min by using a low-temperature ultracentrifuge at 20000rpm/min, and collecting the precipitate to obtain a gold-induced polymerization polypyrrole AuPPy nano material;
s2, gold-induced polymerization polypyrrole/manganese dioxide nanocomposite (AuPPy @ MnO)2) Preparation of
Dropwise adding 25mL of potassium permanganate aqueous solution (200 mu g/mL) into 25mL of AuPPy aqueous solution (200 mu g/mL) prepared from the AuPPy nano material obtained in the step S1 under the condition of low-speed stirring at 200rpm, transferring the AuPPy aqueous solution into a constant-temperature water bath kettle at 40 ℃, and carrying out vigorous stirring reaction at 1000rpm for 1 hour; centrifuging at 15000rpm/min for 10min after the reaction is finished, collecting precipitate, washing with deionized water for three times to obtain the gold-induced polymerized polypyrrole/manganese dioxide nanocomposite (AuPPy @ MnO)2)。
Example 2 gold-induced polypyrrole/manganese dioxide nanomaterial
The preparation method of the gold-induced polypyrrole/manganese dioxide nano material comprises the following steps:
s1 preparation of gold-induced polymerized polypyrrole nano material (AuPPy)
Adding 10mL of deionized water into a 50mL single-neck round-bottom flask, adding 50mg of polyvinylpyrrolidone, mildly stirring at a heating environment of 90 ℃, condensing and refluxing for 1 hour, and naturally cooling to room temperature; dropwise adding 5mL of tetrachloroauric acid dihydrate aqueous solution (10mM) under the stirring condition of the rotation speed of 500-1200 rpm, and continuing stirring for 1 hour; dropwise adding 200 mu L of pyrrole monomer, and stirring at 500-1200 rpm for reaction for 15 minutes; centrifuging the reaction solution for 10min at 30000rpm/min by using a low-temperature ultracentrifuge, and collecting precipitates to obtain a gold-induced polymerization polypyrrole AuPPy nano material;
s2, gold-induced polymerization polypyrrole/manganese dioxide nanocomposite (AuPPy @ MnO)2) Preparation of
Dropwise adding 25mL of potassium permanganate aqueous solution (200 mu g/mL) into 25mL of AuPPy aqueous solution (200 mu g/mL) prepared from the AuPPy nano material obtained in the step S1 under the condition of low-speed stirring at 200rpm, transferring the AuPPy aqueous solution into a constant-temperature water bath kettle at 50 ℃, and carrying out vigorous stirring reaction at 1000rpm for 1 hour; centrifuging at 20000rpm/min for 10min after the reaction is finished, collecting precipitate, washing with deionized water for three times to obtain gold-induced polymerization polypyrrole/manganese dioxide nanocomposite (AuPPy @ MnO)2)。
The gold-induced polypyrrole/manganese dioxide nanomaterial prepared in example 1 is used as an example to perform structural characteristics and performance tests, and other examples can achieve similar effects.
Test example 1 determination of physical and chemical Properties of gold-induced polypyrrole/manganese dioxide nanomaterial
The polypyrrole AuPPy nanomaterial obtained by gold induced polymerization in step S1 of example 1 was subjected to electron microscope scanning analysis, and the result is shown in fig. 1. As can be seen from the figure, the polypyrrole AuPPy nanometer material obtained by the gold-induced polymerization in the example 1 shows uniform loading of ultra-small gold nanoparticles, and the AuPPy nanometer material has uniform particle size distribution and the size of 35-50 nm.
For AuPPy @ MnO obtained in step S2 of example 12The nanocomposite was subjected to electron microscopy scanning analysis and the results are shown in figure 2. As can be seen, AuPPy @ MnO obtained in example 12The surface of the nano composite material becomes rough and the size is largerThe size of the AuPPy nano material is increased to 40-55 nm, which indicates that the manganese dioxide is successfully coated.
For AuPPy @ MnO obtained in example 12The nanocomposite was subjected to energy dispersive X-ray spectroscopy, and the results are shown in fig. 3. As can be seen, AuPPy @ MnO2The existence of Mn, Au, C, N and O elements in the nano composite material indicates that the AuPPy @ MnO of the invention2The nano composite material is successfully prepared.
AuPPy nanomaterial obtained in example 1, AuPPy @ MnO2The X-ray photoelectron spectroscopy (XPS) analysis of the nanocomposite material resulted in the results shown in FIG. 4. As can be seen, AuPPy @ MnO is relative to the XPS spectrum of AuPPy nano material2Mn element is newly added in the nano composite material, which shows the successful coating of manganese dioxide and AuPPy @ MnO2Successful preparation of nanocomposites.
AuPPy nanomaterial obtained in example 1, AuPPy @ MnO2The results of the particle size distribution analysis of the nanocomposites are shown in FIG. 5. As can be seen, the hydrodynamic particle size of the AuPPy nano material is about 134nm, and the AuPPy @ MnO is2The hydrodynamic particle size of the nanocomposite was increased, at around 186nm, indicating successful coating of manganese dioxide in the present invention.
AuPPy nanomaterial obtained in example 1, AuPPy @ MnO2The results of Zeta potential analysis of each nanocomposite are shown in FIG. 6. As can be seen from the figure, the Zeta potential of the AuPPy nano material is about 8.32mV, and the AuPPy @ MnO is coated by manganese dioxide2The Zeta potential of the nano composite material is about-33.97 mV.
Experimental example 2AuPPy @ MnO2Determination of optical Properties of nanocomposites
For AuPPy @ MnO obtained in example 12The optical absorption intensity of the nanocomposite was measured, and the results are shown in fig. 7. As can be seen, AuPPy @ MnO2The nano composite material has strong optical absorption in ultraviolet-visible light-near infrared region and has concentration dependence.
Under the condition of laser with wavelength of 1064nm, AuPPy @ MnO with different concentrations2NanocompositeThe photothermal properties of the materials were evaluated and the results are shown in fig. 8.
As can be seen in FIG. 8A, AuPPy @ MnO2The nano composite material has higher temperature rise under the excitation of 1064nm laser and excellent photo-thermal performance. As can be seen in FIG. 8B, AuPPy @ MnO2After the nano composite material is irradiated by five cycles of 1064nm laser, the nano composite material still shows strong light stability, and the phenomenon of weakened photo-thermal performance does not occur. To sum up, AuPPy @ MnO2The nano composite material has the temperature required by photo-thermal treatment for burning tumors.
Experimental example 3AuPPy @ MnO2Determination of tumor microenvironment improvement performance of nano composite material
For AuPPy @ MnO obtained in example 12The oxygen production capacity of the nano composite material is tested, and the testing method comprises the following steps: different concentrations of AuPPy @ MnO2The nanocomposite was dispersed in phosphate buffer (pH 7.4) and H was added once with a syringe2O2(10mM), the oxygen concentration of the solution at different time points was measured using a JPSJ-605F portable dissolved oxygen meter. The results are shown in FIG. 9.
As can be seen, AuPPy @ MnO2The nano composite material has strong oxygen generation capacity and concentration dependence, and can relieve the tumor hypoxia state and promote radiotherapy.
For AuPPy @ MnO obtained in example 12The glutathione consumption capability of the nano composite material is tested, and the test method comprises the following steps: different concentrations of AuPPy @ MnO2The nanocomposite was dispersed in phosphate buffer (pH 7.4), then 0.1mM GSH was added, and finally the consumption of GSH was detected using a 5,5' -dithiobis (2-nitrobenzoic acid) probe. The results are shown in FIG. 10.
As can be seen, AuPPy @ MnO2The nano composite material has obvious glutathione removing capacity, can reduce the oxidation resistance of tumors and further promotes the radiotherapy effect.
To sum up, AuPPy @ MnO2The nano composite material has the capabilities of improving the oxygen concentration of a tumor microenvironment and consuming glutathione, can assist in enhancing the radiotherapy effect, and has the capabilities of killing tumors and preventing tumor recurrence and metastasis.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Claims (10)
1. A preparation method of gold-induced polypyrrole/manganese dioxide nano material is characterized by comprising the following steps:
s1, mixing the stabilizer, the oxidant and the pyrrole monomer, stirring and reacting at 4-40 ℃, centrifuging, and collecting precipitates to obtain the polypyrrole nano material;
s2, preparing the polypyrrole nano material obtained in the step S1 into a polypyrrole aqueous solution, adding potassium permanganate, reacting completely at 20-60 ℃, centrifuging, collecting precipitate, and performing post-treatment to obtain the polypyrrole nano material;
wherein the oxidant is selected from one or more of tetrachloroauric acid trihydrate, tetrachloroauric acid dihydrate, sodium tetrachloroauric acid and potassium tetrachloroauric acid.
2. The method according to claim 1, wherein in step S1, the stabilizer is one or more selected from polyvinyl alcohol, polyvinylpyrrolidone, and sodium dodecyl sulfate.
3. The method according to claim 1, wherein the stabilizer is added in an amount of 0.1 to 10mg/mL in step S1.
4. The method according to claim 1, wherein in step S1, the oxidizing agent is added after being dissolved in 0.01-30 mM of the oxidizing agent solution in an amount of 1-10 mL.
5. The method according to claim 1, wherein in step S1, the volume ratio of the pyrrole monomer to the total volume of the solution is 1: (10-200).
6. The preparation method according to claim 1, wherein in step S2, the concentration ratio of the potassium permanganate to the polypyrrole nano-materials in the aqueous solution is 1 (0.5-3).
7. A gold-induced polypyrrole/manganese dioxide nanomaterial prepared by the preparation method of any one of claims 1 to 6.
8. The nanomaterial of claim 7, wherein the gold-induced polypyrrole/manganese dioxide nanomaterial has a particle size of 5-200 nm.
9. The use of the gold-induced polypyrrole/manganese dioxide nanomaterial of claim 7 in the preparation of a medicament for the prevention and treatment of tumors.
10. Use according to claim 9, wherein the medicament is combined with radiotherapy and/or photothermal therapy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110915680.XA CN113694196A (en) | 2021-08-10 | 2021-08-10 | Gold-induced polypyrrole/manganese dioxide nano material and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110915680.XA CN113694196A (en) | 2021-08-10 | 2021-08-10 | Gold-induced polypyrrole/manganese dioxide nano material and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113694196A true CN113694196A (en) | 2021-11-26 |
Family
ID=78652211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110915680.XA Pending CN113694196A (en) | 2021-08-10 | 2021-08-10 | Gold-induced polypyrrole/manganese dioxide nano material and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113694196A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102219998A (en) * | 2011-06-01 | 2011-10-19 | 山东大学 | Method for preparing polypyrrole/gold nano composite |
| CN111588852A (en) * | 2020-05-21 | 2020-08-28 | 山西大学 | Polypyrrole/manganese dioxide-methylene blue nano composite particle and preparation method thereof |
-
2021
- 2021-08-10 CN CN202110915680.XA patent/CN113694196A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102219998A (en) * | 2011-06-01 | 2011-10-19 | 山东大学 | Method for preparing polypyrrole/gold nano composite |
| CN111588852A (en) * | 2020-05-21 | 2020-08-28 | 山西大学 | Polypyrrole/manganese dioxide-methylene blue nano composite particle and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| XUAN YI ET AL: "Core–shell Au@MnO2 nanoparticles for enhanced radiotherapy via improving the tumor oxygenation", 《NANO RESEARCH》 * |
| 邹全 等: "氯金酸介导聚吡咯氧化聚合用于癌症成像及治疗", 《中国化学会第十三届全国分析化学年会论文集（一）》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108434462B (en) | Multifunctional nano diagnosis and treatment agent with mesoporous polydopamine loaded carbonyl manganese and preparation method and application thereof | |
| Guo et al. | Biocompatible chitosan-carbon nanocage hybrids for sustained drug release and highly efficient laser and microwave co-irradiation induced cancer therapy | |
| CN108578716B (en) | Polydopamine-coated magnetic mesoporous silica nano material and preparation and application thereof | |
| Zhang et al. | A hybrid nanomaterial with NIR-induced heat and associated hydroxyl radical generation for synergistic tumor therapy | |
| CN106620702A (en) | Preparation method of gold/nitrogen-doped hollow carbon nanosphere core-shell material | |
| CN109289050B (en) | Ferroferric oxide/polypyrrole/glucose oxidase composite multifunctional nano diagnosis and treatment agent and preparation method and application thereof | |
| Chen et al. | Graphitic carbon nanocages as new photothermal agent and drug Carrier for 980-nm-laser-driven cancer therapy | |
| CN108969766A (en) | Photosensitized composite material and preparation method with tumor microenvironment response oxygenation performance | |
| CN110404071A (en) | A kind of tumour diagnosis and treatment reagent of glutathione triggering | |
| CN107670039B (en) | Catalase and photosensitive molecule compound and preparation method and application thereof | |
| CN113679838A (en) | Vanadium nano enzyme and preparation method and application thereof | |
| CN110559438B (en) | Photothermal and photodynamic diagnosis and treatment integrated reagent guided by nuclear magnetic resonance imaging and preparation method thereof | |
| CN110538331B (en) | Method for preparing magnetic nano-particles with improved dispersibility and particle uniformity | |
| CN113694196A (en) | Gold-induced polypyrrole/manganese dioxide nano material and preparation method and application thereof | |
| CN113912872A (en) | Polypyrrole nanoparticle for copper-induced oxidative polymerization and preparation method and application thereof | |
| Lane et al. | Effects of core titanium crystal dimension and crystal phase on ROS generation and tumour accumulation of transferrin coated titanium dioxide nanoaggregates | |
| CN107890566A (en) | A kind of diagnosing tumor treatment preparation and its preparation method and application | |
| CN110354264B (en) | Preparation method of Ce 6-loaded oxygen-deficient zirconium dioxide nanoparticles | |
| CN114177289A (en) | Composite nano material for photodynamic and photothermal combined treatment and preparation method and application thereof | |
| Xue et al. | Porous Prussian blue nanocubes as photothermal ablation agents for efficient cancer therapy | |
| CN113813379A (en) | Gold nanoparticle with stable carbon quantum dots and preparation method and application thereof | |
| CN113750233A (en) | Nano composite material and preparation method and application thereof | |
| Perota et al. | A Study of Sonodynamic Therapy of Melanoma C540 Cells in Vitro by Titania/Gold Nanoparticles | |
| Sun et al. | Modulation of two-dimensional palladium nanozyme activity to enhance chemodynamic/photothermal combined therapy for melanoma | |
| CN114699526B (en) | Phycocyanin mineralized nanoparticle as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211126 |
|
| RJ01 | Rejection of invention patent application after publication |